Top

Journal of Nuclear Cardiology

Published in:

01-08-2011 | Review Article

The ninth annual Mario S. Verani memorial lecture

Testing our tests: The evidence bar is rising. Regulatory considerations in the development of cardiac imaging agents

Author: James E. Udelson, MD

Published in: Journal of Nuclear Cardiology | Issue 4/2011

Excerpt

It is indeed an enormous honor and a privilege to have been invited to present the ninth annual Mario S. Verani memorial lecture. It has been almost 10 years since Mario left us, and it is likely that many here with us today at the American Society of Nuclear Cardiology Annual meeting are not very aware of the major contributions he made to our field. As one of the purposes of this annual lectureship is to honor that body of work, and carry on its legacy, I thought it would be fitting to start with a reminiscence of the mark he made on the field of Nuclear Cardiology. …

Verani MS, Marcus ML, Razzak MA, Ehrhardt JC. Sensitivity and specificity of thallium-201 perfusion scintigrams under exercise in the diagnosis of coronary artery disease. J Nucl Med 1978;19:773-82.PubMed

Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80-7.PubMedCrossRef

He ZX, Cwajg E, Hwang W, Hartley CJ, Funk E, Michael LH, et al. Myocardial blood flow and myocardial uptake of (201)Tl and (99m)Tc-sestamibi during coronary vasodilation induced by CGS-21680, a selective adenosine A(2A) receptor agonist. Circulation 2000;102:438-44.PubMed

Verani MS, Hartung GH, Hoepfel-Harris J, Welton DE, Pratt CM, Miller RR. Effects of exercise training on left ventricular performance and myocardial perfusion in patients with coronary artery disease. Am J Cardiol 1981;47:797-803.PubMedCrossRef

Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, et al. Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study. Circulation 1996;94:1010-7.PubMed

Verani MS, Jeroudi MO, Mahmarian JJ, Boyce TM, Borges-Neto S, Patel B, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988;12:1573-81.PubMedCrossRef

Gibbons RJ, Miller TD, Christian TF. Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000;101:101-8.PubMed

Mahmarian JJ, Boyce TM, Goldberg RK, Cocanougher MK, Roberts R, Verani MS. Quantitative exercise thallium-201 single photon emission computed tomography for the enhanced diagnosis of ischemic heart disease. J Am Coll Cardiol 1990;15:318-29.PubMedCrossRef

Verani MS, Lacy JL, Guidry GW, Nishimura S, Mahmarian JJ, Athanasoulis T, et al. Quantification of left ventricular performance during transient coronary occlusion at various anatomic sites in humans: A study using tantalum-178 and a multiwire gamma camera. J Am Coll Cardiol 1992;19:297-306.PubMedCrossRef

10.

Verani MS, Gaeta J, LeBlanc AD, Poliner LR, Phillips L, Lacy JL, et al. Validation of left ventricular volume measurements by radionuclide angiography. J Nucl Med 1985;26:1394-401. (Erratum in: J Nucl Med 1987;28:401-2).PubMed

11.

He ZX, Scarlett MD, Mahmarian JJ, Verani MS. Enhanced accuracy of defect detection by myocardial single-photon emission computed tomography with attenuation correction with gadolinium 153 line sources: Evaluation with a cardiac phantom. J Nucl Cardiol 1997;4:202-10.PubMedCrossRef

12.

Verani MS. Stress myocardial perfusion imaging versus echocardiography for the diagnosis and risk stratification of patients with known or suspected coronary artery disease. Semin Nucl Med 1999;29:319-29.PubMedCrossRef

13.

Zaret BL, Strauss HW, Martin ND, Wells HP, Flamm MD. Noninvasive regional myocardial perfusion with radioactive potassium—study of patients at rest, with exercise and during angina pectoris. N Engl J Med 1973;288:809-12.PubMedCrossRef

14.

Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990;323:141-6.PubMedCrossRef

15.

http://www.fda.gov/AboutFDA/Transparency/Basics/ucm192695.htm. Accessed May 10, 2011

16.

http://www.fda.gov/AboutFDA/Transparency/Basics/ucm194909.htm. Accessed May 10, 2011

17.

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=10.115. Accessed May 10, 2011

18.

Guidance for Industry. Developing medical imaging drug and biological products part 2: Clinical Indications. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071603.pdf. Accessed May 11, 2011

19.

Guidance for Industry. Developing medical imaging drug and biological products part 3: Design, analysis, and interpretation of clinical studies. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071604.pdf. Accessed May 11, 2011

20.

Boucher CA, Wackers FJ, Zaret BL, Mena IG. Technetium-99m sestamibi myocardial imaging at rest for assessment of myocardial infarction and first-pass ejection fraction. Multicenter Cardiolite Study Group. Am J Cardiol 1992;69:22-7.PubMedCrossRef

21.

http://www.orgyn.com/resources/genrx/D003020.asp. Accessed May 11, 2011

22.

http://www.drugs.com/pro/technetium-tc-99m-sestamibi.html. Accessed May 11, 2011

23.

http://www.cardiogen.com/uploads/PDF/WebsiteIntroductiontoCardioGenPowerPoint.ppt#267,7,CardioGen-82® (Rubidium Rb 82 Generator). Accessed May 10, 2011

24.

Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. ESC/ACCF/AHA/WHF EXPERT CONSENSUS DOCUMENT: Universal definition of myocardial infarction. J Am Coll Cardiol 2007;50:2173-95.PubMedCrossRef

25.

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.PubMedCrossRef

26.

Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study. Lancet 2003;361:374-9.PubMedCrossRef

27.

Gould KL, Westcott RJ, Albro PC, Hamilton GW. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility. Am J Cardiol 1978;41:279-87.PubMedCrossRef

28.

Al Suwaidi J, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.

29.

Senior R, Monaghan M, Main ML, Zamorano JL, Tiemann K, Agati L, et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: Two Phase 3 international trials in comparison with radionuclide perfusion imaging. Eur J Echocardr 2009;10:26-35.CrossRef

30.

Zir LM, Miller SW, Dinsmore RE, Gilbert JP, Harthorne JW. Interobserver variability in coronary angiography. Circulation 1976;53:627-32.PubMed

31.

Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 1995;91:1944-51.PubMed

32.

Hodgson JM, Dib N, Kern MJ, Bach RG, Barrett RJ. Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist. Am J Cardiol 2007;99:1507-12.PubMedCrossRef

33.

Borer JS, Bacharach SL, Green MV, Kent KM, Epstein SE, Johnston GS, et al. Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease. N Engl J Med 1977;296:839-44.PubMedCrossRef

34.

Zaret BL, Rigo P, Wackers FJT, Hendel RC, Braat SH, Iskandrian AS, et al. Myocardial perfusion imaging with ^99mTc tetrofosmin comparison to ²⁰¹Tl imaging and coronary angiography in a phase III multicenter trial. Circulation 1995;91:313-9.PubMed

35.

http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-059S007_Adenoscan.pdf. Accessed May 11, 2011

36.

Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol 2007;14:645-58.PubMedCrossRef

37.

The ASPECT Trial: A Phase III, Randomized, Double-Blind Crossover Trial of Apadenoson for the Detection of Myocardial Perfusion Defects Using Single-Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI). Clinicaltrials.gov identifier NCT00990327. http://www.clinicaltrials.gov/ct2/show/NCT00990327?term=apadenoson&rank=1. Accessed May 11, 2011

38.

Udelson JE. Lessons from the development of new adenosine A2a receptor agonists. J Am Coll Cardiol Imaging 2008;1:317-20.

39.

Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: A randomized controlled trial. JAMA 2002;288:2693-700.PubMedCrossRef

40.

Rule out Myocardial Infarction by Computer Assisted Tomography. Clinicaltrials.gov identifier NCT00990262. http://www.clinicaltrials.gov/ct2/show/NCT00990262?term=romicat+2&rank=1. Accessed May 12, 2011

41.

Coronary Computed Tomography for Systematic Triage of Acute Chest Pain Patients to Treatment (CT-STAT) clinicaltrials.gov identifier NCT00468325. http://www.clinicaltrials.gov/ct2/show/NCT00468325?term=CT+STAT&rank=1. May 11, 2001

42.

Kontos MC, Dilsizian V, Weiland F, DePuey G, Mahmarian JJ, Iskandrian AE, et al. Iodofiltic acid I 123 (BMIPP) fatty acid imaging improves initial diagnosis in emergency department patients with suspected acute coronary syndromes: A multicenter trial. J Am Coll Cardiol 2010;56:290-9.PubMedCrossRef

43.

Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994-1001.PubMedCrossRef

44.

Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71.PubMedCrossRef

45.

Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.PubMed

46.

Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial Iodine-123 Meta-iodobenzylguanidine imaging and cardiac events in heart failure: Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) Study. J Am Coll Cardiol 2010;55:2212-21.PubMedCrossRef

47.

Young LH, Wackers FJT, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: The DIAD Study: A randomized controlled trial. JAMA 2009;301:1547-55.PubMedCrossRef

48.

PROspective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. Clinicaltrials.gov identifier NCT01174550. http://clinicaltrials.gov/ct2/show/NCT01174550?term=PROMISE&rank=6. Accessed May 11, 2011

Title: The ninth annual Mario S. Verani memorial lecture
Testing our tests: The evidence bar is rising. Regulatory considerations in the development of cardiac imaging agents
Author: James E. Udelson, MD
Publication date: 01-08-2011
Publisher: Springer-Verlag
Published in: Journal of Nuclear Cardiology / Issue 4/2011
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-011-9404-x

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The ninth annual Mario S. Verani memorial lecture

Testing our tests: The evidence bar is rising. Regulatory considerations in the development of cardiac imaging agents

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2011

Erratum to: Cardiac risk assessment in asymptomatic diabetes: Combining different imaging modalities and surrogate markers?

Positron emission tomography scan can be a reassuring tool to treat difficult cases of infective endocarditis

Controversies in nuclear cardiology: CT calcium scoring should be routinely performed in patients undergoing myocardial perfusion imaging who have a normal test result (and should be routinely performed before myocardial perfusion imaging)—pro

Gender disparity and the appropriateness of myocardial perfusion imaging

AUC for SPECT: Is gender bias inappropriate

Imaging of vulnerable plaques: Will it affect patient management and influence outcomes?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page